Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Correction: BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications.
Leukemia ( IF 12.8 ) Pub Date : 2020-01-16 , DOI: 10.1038/s41375-020-0705-4 Jooeun Bae 1, 2 , Neha Parayath 3 , Wenxue Ma 4 , Mansoor Amiji 5 , Nikhil Munshi 1, 2 , Kenneth C Anderson 1, 2
Leukemia ( IF 12.8 ) Pub Date : 2020-01-16 , DOI: 10.1038/s41375-020-0705-4 Jooeun Bae 1, 2 , Neha Parayath 3 , Wenxue Ma 4 , Mansoor Amiji 5 , Nikhil Munshi 1, 2 , Kenneth C Anderson 1, 2
Affiliation
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
中文翻译:
校正:BCMA肽工程化的纳米颗粒可增强针对多发性骨髓瘤的抗原特异性CD8 +细胞毒性T淋巴细胞的诱导和功能:临床应用。
该文件的修订版已经发布,可以通过文件顶部的链接进行访问。
更新日期:2020-01-16
中文翻译:
校正:BCMA肽工程化的纳米颗粒可增强针对多发性骨髓瘤的抗原特异性CD8 +细胞毒性T淋巴细胞的诱导和功能:临床应用。
该文件的修订版已经发布,可以通过文件顶部的链接进行访问。